Categories: HealthDay

11/30/2018

Independent source injects caution into a HeathDay story on ‘nerve zap’ for back pain

10/18/2018

HealthDay touts nerve device as ‘more effective,’ but data is from unpublished study with no control group

10/2/2018

Are bacteria useful as cancer ‘weapons,’ or far too early to know? Key context missing from HealthDay story

8/20/2018

Talazoparib touted as ‘promising,’ but is it any better than a similar breast cancer drug that’s already available?

6/22/2018

One blood test to diagnose diabetes? HealthDay doesn’t address harms of overdiagnosis and overtreatment

Story Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

HealthNewsRevuHealthNewsReview.org@HealthNewsRevu·

Come on, NY Times; you must do better than this. Important research doesn’t need hype and the “breaking news” BS doesn’t help readers or patients. https://www.healthnewsreview.org/2022/03/nyt-proclaims-breaking-news/

Reply on Twitter 1506684595651035136Retweet on Twitter 15066845956510351361Like on Twitter 15066845956510351364Twitter 1506684595651035136
HealthNewsRevuHealthNewsReview.org@HealthNewsRevu·

Our editorial team was blessed to have Sharon as a contributor during our best years. As this obit states, she was “kind, patient, wise, thoughtful and generous.” Thank you, Sharon; now rest in peace. https://journalism.wisc.edu/news/in-memoriam-sharon-dunwoody-1947-2022/

Reply on Twitter 1490898576763125760Retweet on Twitter 1490898576763125760Like on Twitter 14908985767631257602Twitter 1490898576763125760
HealthNewsRevuHealthNewsReview.org@HealthNewsRevu·

We’ve written about the hype of liquid biopsies for years (see link in comment below). And now this…. https://www.statnews.com/2022/01/12/medicare-shouldnt-cover-liquid-biopsies-early-cancer-detection/

Reply on Twitter 1481386325567852553Retweet on Twitter 14813863255678525531Like on Twitter 14813863255678525536Twitter 1481386325567852553
View More

Categories

View More

Tags